129 related articles for article (PubMed ID: 16026008)
21. Synthesis and antitumor activity of 20-O-linked nitrogen-based camptothecin ester derivatives.
Wang CY; Pan XD; Liu HY; Fu ZD; Wei XY; Yang LX
Bioorg Med Chem; 2004 Jul; 12(13):3657-62. PubMed ID: 15186850
[TBL] [Abstract][Full Text] [Related]
22. The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity.
Bom D; Curran DP; Kruszewski S; Zimmer SG; Thompson Strode J; Kohlhagen G; Du W; Chavan AJ; Fraley KA; Bingcang AL; Latus LJ; Pommier Y; Burke TG
J Med Chem; 2000 Oct; 43(21):3970-80. PubMed ID: 11052802
[TBL] [Abstract][Full Text] [Related]
23. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
[TBL] [Abstract][Full Text] [Related]
24. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.
Xing J; Zhang X; Wang Z; Zhang H; Chen P; Zhou G; Sun C; Gu N; Ji M
Int J Nanomedicine; 2019; 14():5201-5213. PubMed ID: 31371956
[No Abstract] [Full Text] [Related]
25. Modified lactone/carboxylate salt equilibria in vivo by liposomal delivery of 9-nitro-camptothecin.
Chow DS; Gong L; Wolfe MD; Giovanella BC
Ann N Y Acad Sci; 2000; 922():164-74. PubMed ID: 11193891
[TBL] [Abstract][Full Text] [Related]
26. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles.
Kawano K; Watanabe M; Yamamoto T; Yokoyama M; Opanasopit P; Okano T; Maitani Y
J Control Release; 2006 May; 112(3):329-32. PubMed ID: 16678929
[TBL] [Abstract][Full Text] [Related]
27. MEN4901/T-0128, a new camptothecin derivative-carboxymethyldextran conjugate, has potent antitumor activities in a panel of human tumor xenografts in nude mice.
Fujita F; Koike M; Fujita M; Sakamoto Y; Okuno S; Kawaguchi T; Yano S; Yano T; Kiuchi S; Fujiwara T; Kudoh S; Kakushima M
Clin Cancer Res; 2005 Feb; 11(4):1650-7. PubMed ID: 15746070
[TBL] [Abstract][Full Text] [Related]
28. Conjugation of camptothecins to poly-(L-glutamic acid).
Singer JW; De Vries P; Bhatt R; Tulinsky J; Klein P; Li C; Milas L; Lewis RA; Wallace S
Ann N Y Acad Sci; 2000; 922():136-50. PubMed ID: 11193889
[TBL] [Abstract][Full Text] [Related]
29. Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.
Sapra P; Zhao H; Mehlig M; Malaby J; Kraft P; Longley C; Greenberger LM; Horak ID
Clin Cancer Res; 2008 Mar; 14(6):1888-96. PubMed ID: 18347192
[TBL] [Abstract][Full Text] [Related]
30. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies.
Zhang H; Wang J; Mao W; Huang J; Wu X; Shen Y; Sui M
J Control Release; 2013 Mar; 166(2):147-58. PubMed ID: 23266448
[TBL] [Abstract][Full Text] [Related]
31. Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization.
Rose WC; Marathe PH; Jang GR; Monticello TM; Balasubramanian BN; Long B; Fairchild CR; Wall ME; Wani MC
Cancer Chemother Pharmacol; 2006 Jul; 58(1):73-85. PubMed ID: 16228206
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
33. Complete regression of xenografted human carcinomas by camptothecin analogue-carboxymethyl dextran conjugate (T-0128).
Okuno S; Harada M; Yano T; Yano S; Kiuchi S; Tsuda N; Sakamura Y; Imai J; Kawaguchi T; Tsujihara K
Cancer Res; 2000 Jun; 60(11):2988-95. PubMed ID: 10850447
[TBL] [Abstract][Full Text] [Related]
34. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
35. Bifunctional supramolecular prodrug vesicles constructed from a camptothecin derivative with a water-soluble pillar[5]arene for cancer diagnosis and therapy.
Sun G; He Z; Hao M; Xu Z; Hu XY; Zhu JJ; Wang L
Chem Commun (Camb); 2019 Sep; 55(73):10892-10895. PubMed ID: 31436766
[TBL] [Abstract][Full Text] [Related]
36. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues.
Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A
Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631
[TBL] [Abstract][Full Text] [Related]
37. The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer.
Ji Y; Hayashi K; Amoh Y; Tsuji K; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Bouvet M; Hoffman RM
Anticancer Res; 2007; 27(2):713-8. PubMed ID: 17465193
[TBL] [Abstract][Full Text] [Related]
38. Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.
Kumazawa E; Jimbo T; Ochi Y; Tohgo A
Cancer Chemother Pharmacol; 1998; 42(3):210-20. PubMed ID: 9685056
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis, and Biological Evaluation of New Cathepsin B-Sensitive Camptothecin Nanoparticles Equipped with a Novel Multifuctional Linker.
Zhang X; Tang K; Wang H; Liu Y; Bao B; Fang Y; Zhang X; Lu W
Bioconjug Chem; 2016 May; 27(5):1267-75. PubMed ID: 27070848
[TBL] [Abstract][Full Text] [Related]
40. Improving anticancer activity and selectivity of camptothecin through conjugation with releasable substance P.
Zhang W; Song J; Mu L; Zhang B; Liu L; Xing Y; Wang K; Li Z; Wang R
Bioorg Med Chem Lett; 2011 Mar; 21(5):1452-5. PubMed ID: 21282053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
